Drug combo helps women with early breast cancer

December 10, 2010 By MARILYNN MARCHIONE , AP Medical Writer

(AP) -- A new study finds that using two drugs, Herceptin (her-SEPT-in) and Tykerb (TIE-curb), more than doubles the number of women with early breast cancer whose tumors disappear before they are scheduled to have surgery to remove them.

These drugs target a that is overproduced in about one-fourth of all breast cancers. In the study, about 450 women getting chemotherapy were also given Herceptin or Tykerb or both drugs. Half of the women on the combination saw their tumors disappear versus only 20 percent of those taking either drug alone.

GlaxoSmithKline PLC makes Tykerb. Roche's Genentech division makes Herceptin. Doctors discussed the study Friday at a conference in San Antonio.

Explore further: Herceptin helps women with multiple chromosomes containing HER2 gene, study finds


Related Stories

Drug combination shrinks breast cancer metastases in brain

December 16, 2007

A combination of a "targeted" therapy and chemotherapy shrank metastatic brain tumors by at least 50 percent in one-fifth of patients with aggressive HER2-positive breast cancer, according to data presented by Dana-Farber ...

Herceptin targets breast cancer stem cells

July 9, 2008

A gene that is overexpressed in 20 percent of breast cancers increases the number of cancer stem cells, the cells that fuel a tumor's growth and spread, according to a new study from the University of Michigan Comprehensive ...

Novel drug combo improves breast cancer survival

December 11, 2009

(AP) -- Some women with very advanced breast cancer may have a new treatment option. A combination of two drugs that more precisely target tumors significantly extended the lives of women who had stopped responding to other ...

Recommended for you

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

Machine Translates Thoughts into Speech in Real Time

December 21, 2009

(PhysOrg.com) -- By implanting an electrode into the brain of a person with locked-in syndrome, scientists have demonstrated how to wirelessly transmit neural signals to a speech synthesizer. The "thought-to-speech" process ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.